• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

autoimmune disease

  • New study: Immune cells linked to Epstein-Barr virus may play a role in MS
    February 6, 2026

    New study: Immune cells linked to Epstein-Barr virus may play a role in MS

    scientificinquirer
  • DAILY DOSE: Listeria Outbreak Hospitalizes Ten, Triggers Multistate Recall; DEI Content Erased From Space Institute Archives.
    May 12, 2025

    DAILY DOSE: Listeria Outbreak Hospitalizes Ten, Triggers Multistate Recall; DEI Content Erased From Space Institute Archives.

    scientificinquirer
  • Researchers discover a major driver of inflammatory pathology in autoimmune and chronic inflammatory diseases
    March 13, 2025

    Researchers discover a major driver of inflammatory pathology in autoimmune and chronic inflammatory diseases

    bricemarsters
  • New discovery could change autoimmune therapy landscape, study suggests
    November 10, 2024

    New discovery could change autoimmune therapy landscape, study suggests

    bricemarsters
  • Treatment for major cause of recurrent pregnancy loss
    September 30, 2024

    Treatment for major cause of recurrent pregnancy loss

    bricemarsters
  • Autoimmune disease not associated with monoclonal gammopathy
    May 25, 2024

    Autoimmune disease not associated with monoclonal gammopathy

    bricemarsters
  • Scientists find a genetic cause of lupus.
    April 29, 2022

    Scientists find a genetic cause of lupus.

    bricemarsters
  • Ginger shows some effectiveness against autoimmune diseases.
    January 7, 2021

    Ginger shows some effectiveness against autoimmune diseases.

    scientificinquirer
  • Exercise and stress help reduce Lupus inflammation, study
    September 18, 2017

    Exercise and stress help reduce Lupus inflammation, study

    scientificinquirer
  • Treating autoimmune dysfunction with a more targeted approach
    May 31, 2017

    Treating autoimmune dysfunction with a more targeted approach

    scientificinquirer

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
 

Loading Comments...